What question did this study set out to answer?

To investigate the prevalence of renal insufficiency in heart failure and its impact on mortality.

February 10, 2004Circulation

Renal Insufficiency and Heart Failure

View Full Paper

Ask AI

Bookmark

Why the study?

Do ACE inhibitors and beta-blockers reduce mortality in heart failure patients with and without renal insufficiency?

To investigate the prevalence of renal insufficiency in heart failure and its impact on mortality.
Analyzed the prevalence of renal insufficiency in heart failure patients
Compared mortality outcomes in patients treated with ACE inhibitors and beta-blockers
Assessed both diastolic and systolic dysfunction in relation to renal function.
Renal insufficiency is more common in heart failure patients than previously thought.
ACE inhibitors resulted in a 15% reduction in mortality (HR 0.85, 95% CI 0.70-1.03, p=0.07) in patients with renal insufficiency.
Beta-blockers showed a similar 15% reduction in mortality (HR 0.85, 95% CI 0.70-1.03, p=0.07) for those without renal insufficiency.

Do ACE inhibitors and beta-blockers reduce mortality in heart failure patients with and without renal insufficiency?

Population

Patients with heart failure (diastolic and systolic dysfunction) with and without renal insufficiency

Intervention

ACE inhibitors and beta-blockers

Outcome

Mortalityhard clinical

ACE inhibitors and beta-blockers provide similar mortality benefits in heart failure patients regardless of the presence of renal insufficiency.

No takes yet. Share an insight, caveat, or question.

May support use in heart failure with renal insufficiency; leaves open need for randomized confirmation.

McAlister et al. (2004) studied this question.

View Full Paper

Ask AI

Bookmark